Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 13, 2026
Coeur Mining (CDE) Rises +17.5% as Silver Rebounds and Results Improve

Coeur Mining (CDE) Rises +17.5% as Silver Rebounds and Results Improve

Key Takeaways

  • Coeur Mining shares climbed roughly 17.5% over the trailing 30 days, from a closing price of $16.00 on July 14, 2026, to a latest available intraday price near $18.80.
  • The advance was closely tied to a sharp rebound in silver, which recovered from about $56 per ounce in early August toward the $64–$66 range on safe-haven demand, a softer U.S. dollar, and lower Treasury yields.
  • Second-quarter 2026 results showed record quarterly revenue of roughly $1.09 billion and record adjusted EBITDA, even as earnings per share came in below consensus estimates.
  • Management paired the earnings release with a $750 million share repurchase authorization and the company's first dividend in approximately 30 years.
  • Over the trailing quarter, CDE was still modestly lower, leaving the stock in a wide, metal-driven trading range despite the recent rebound.

Coeur Mining (CDE) Company Overview and Market Position

Coeur Mining, Inc. is a Chicago-based precious metals producer with gold, silver, and copper operations across North America. Its portfolio includes the Palmarejo, Rochester, Kensington, Wharf, Silvertip, Las Chispas, New Afton, and Rainy River assets, following acquisitions that expanded its footprint in Canada and Mexico. Management has indicated that roughly 64% of revenue is tied to gold, about 30% to silver, and 6% to copper, giving investors leveraged exposure to precious metals prices while retaining meaningful industrial demand exposure through silver and copper.

Investors follow CDE because the company sits at the intersection of mine production growth, metals price momentum, and an evolving capital-return program. The integration of the New Afton and Rainy River mines has made operational execution a central theme, while Rochester's silver expansion and exploration across existing assets remain longer-term growth drivers. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Coeur Mining (CDE) Stock Price Performance: Last 30 Days vs. Quarter

Over the trailing 30 days, CDE advanced from a $16.00 close on July 14, 2026, to a latest available intraday price of $18.80, a gain of approximately 17.5%. The move was not a straight line: shares pulled back to a July trough near $14.16 before rebounding sharply in early August alongside silver prices and the company's quarterly report.

The longer three-month picture remains more mixed. From a close of $19.74 on May 13, 2026, CDE was down about 4.8% as of the latest available quote. Within that period, the stock reached a mid-May closing high near $20.17, sold off through June and July, and then recovered into mid-August. The stock has moved back above its 50-day moving average while still trading below its 200-day moving average, reflecting a stock that has regained short-term momentum but has not fully reversed its spring-to-summer decline.

What Drove CDE Stock Price in the Last 30 Days

The dominant catalyst over the past month was the recovery in silver. After trading near $56 per ounce in early August, silver climbed to roughly $64–$66 per ounce, supported by safe-haven flows tied to Middle East shipping tensions, a weaker U.S. dollar, and lower Treasury yields following a soft U.S. jobs report. Silver's dual role as both a monetary metal and an industrial input added further support, with demand from solar, electronics, and data-center-related applications remaining a key theme.

Coeur Mining's second-quarter 2026 results, released in early August, provided a second catalyst. The company reported record quarterly revenue of approximately $1.09 billion, up about 126% year over year, alongside record adjusted EBITDA and free cash flow. Earnings per share missed consensus estimates, and management recalibrated 2026 production guidance, but investors focused on the company's balance-sheet strength, a $750 million buyback authorization, and the first dividend in roughly three decades. Heavy trading volume on the earnings day confirmed elevated investor attention.

What Drove CDE Stock Performance Over the Last Quarter

The trailing quarter's modest decline reflects a broader period of volatility in precious metals equities. Earlier in the period, CDE traded near $20 per share, supported by strong silver prices and enthusiasm around the expanded asset base. That momentum faded as silver and gold prices weakened through June, while investors digested integration challenges at the newly acquired New Afton and Rainy River mines.

Operational factors added pressure. Management lowered certain production expectations, cited slower-than-planned underground ramp-ups, and flagged cost inflation, particularly higher diesel and maintenance costs. Non-cash acquisition accounting impacts also weighed on reported earnings. The early-August rebound in silver, combined with the company's capital-return announcements and record cash flow, helped restore sentiment, but CDE still ended the three-month window below its mid-May level.

CDE Stock Forecast Drivers: What Investors Should Watch Next

The most important near-term variable for CDE is the path of silver and gold prices, which will continue to be shaped by Federal Reserve policy expectations, U.S. inflation data, the dollar, Treasury yields, and geopolitical risk. Industrial demand for silver remains a secondary but meaningful driver. From what I see, this is important because metals prices often dictate short-term moves in the sector.

Company-specific factors matter just as much. Investors will be watching whether New Afton reaches its 16,000-ton-per-day mining rate target early in the fourth quarter and whether Rainy River's underground operation achieves 5,000 tons per day by year-end. Cost trends, especially diesel and maintenance, and the remaining non-cash inventory accounting impact expected in the third quarter will also influence reported results. Finally, execution on the buyback and dividend framework, along with any revisions to analyst estimates, could shape sentiment in the months ahead. I’m watching this closely as execution details unfold.

Leveraging Tickeron AI Tools in My Analysis

In my research process, I frequently rely on Tickeron’s AI Trading Bots to monitor automated strategies across various tickers. These tools help filter through hundreds of bots and highlight top performers, allowing me to compare different trading approaches without building systems from scratch. It’s a useful resource for staying on top of market signals in real time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CDE

Momentum Indicator for CDE turns positive, indicating new upward trend

CDE saw its Momentum Indicator move above the 0 level on July 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CDE just turned positive on July 23, 2026. Looking at past instances where CDE's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

CDE moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CDE advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CDE broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CDE entered a downward trend on July 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CDE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.857) is normal, around the industry mean (4.040). P/E Ratio (15.798) is within average values for comparable stocks, (50.974). CDE's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.505). CDE has a moderately low Dividend Yield (0.001) as compared to the industry average of (0.014). P/S Ratio (4.488) is also within normal values, averaging (7.374).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Newmont Corp (NYSE:NEM), Wheaton Precious Metals Corp (NYSE:WPM), Gold Fields Ltd (NYSE:GFI), Kinross Gold Corp (NYSE:KGC), Pan American Silver Corp (NYSE:PAAS), SSR Mining (NASDAQ:SSRM).

Industry description

The Precious Metals industry is engaged in exploring/mining metals that are considered to be rare and/or have a high economic value. Popular precious metals include gold, platinum and silver - all three of which are largely used in jewelry, art and coinage alongwith having some industrial uses as well. Precious metals used in industrial processes include iridium, (used in specialty alloys), and palladium ( used in electronics and chemical applications). Historically, precious metals have traded at much higher prices than common industrial metals. Newmont Goldcorp Corp, Barrick Gold Corp and Freeport-McMoRan are few of the major precious metals producing companies in the U.S.

Market Cap

The average market capitalization across the Precious Metals Industry is 13.21B. The market cap for tickers in the group ranges from 575 to 134.78B. ZIJMF holds the highest valuation in this group at 134.78B. The lowest valued company is DRIFF at 575.

High and low price notable news

The average weekly price growth across all stocks in the Precious Metals Industry was 10%. For the same Industry, the average monthly price growth was 22%, and the average quarterly price growth was -18%. THM experienced the highest price growth at 32%, while NAMM experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Precious Metals Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was 61% and the average quarterly volume growth was -40%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 76
Price Growth Rating: 48
SMR Rating: 65
Profit Risk Rating: 64
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
CDE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company whichc engages in the development and exploration of silver and gold mining properties

Industry PreciousMetals

Profile
Details
Industry
Precious Metals
Address
200 South Wacker Drive
Phone
+1 312 489-5800
Employees
2074
Web
https://www.coeur.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.